JP2003527856A5 - - Google Patents

Download PDF

Info

Publication number
JP2003527856A5
JP2003527856A5 JP2001569332A JP2001569332A JP2003527856A5 JP 2003527856 A5 JP2003527856 A5 JP 2003527856A5 JP 2001569332 A JP2001569332 A JP 2001569332A JP 2001569332 A JP2001569332 A JP 2001569332A JP 2003527856 A5 JP2003527856 A5 JP 2003527856A5
Authority
JP
Japan
Prior art keywords
gene
nucleotide sequence
endogenous target
animal cells
endogenous
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2001569332A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003527856A (ja
Filing date
Publication date
Priority claimed from AUPQ6363A external-priority patent/AUPQ636300A0/en
Priority claimed from AUPR2700A external-priority patent/AUPR270001A0/en
Application filed filed Critical
Priority claimed from PCT/AU2001/000297 external-priority patent/WO2001070949A1/en
Publication of JP2003527856A publication Critical patent/JP2003527856A/ja
Publication of JP2003527856A5 publication Critical patent/JP2003527856A5/ja
Pending legal-status Critical Current

Links

JP2001569332A 2000-03-17 2001-03-16 遺伝子のサイレンシング Pending JP2003527856A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
AUPQ6363A AUPQ636300A0 (en) 2000-03-17 2000-03-17 Genetic silencing
AU6363 2000-03-17
AU2700 2001-01-24
AUPR2700A AUPR270001A0 (en) 2001-01-24 2001-01-24 Genetic silencing
PCT/AU2001/000297 WO2001070949A1 (en) 2000-03-17 2001-03-16 Genetic silencing

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2011179375A Division JP2011229542A (ja) 2000-03-17 2011-08-19 遺伝子のサイレンシング

Publications (2)

Publication Number Publication Date
JP2003527856A JP2003527856A (ja) 2003-09-24
JP2003527856A5 true JP2003527856A5 (https=) 2008-05-15

Family

ID=25646282

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2001569332A Pending JP2003527856A (ja) 2000-03-17 2001-03-16 遺伝子のサイレンシング
JP2011179375A Pending JP2011229542A (ja) 2000-03-17 2011-08-19 遺伝子のサイレンシング

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2011179375A Pending JP2011229542A (ja) 2000-03-17 2011-08-19 遺伝子のサイレンシング

Country Status (12)

Country Link
US (1) US20030182672A1 (https=)
EP (1) EP1272629A4 (https=)
JP (2) JP2003527856A (https=)
KR (1) KR20020097198A (https=)
CN (1) CN1426466A (https=)
AU (1) AU2001240375A1 (https=)
BR (1) BR0109269A (https=)
CA (1) CA2403162A1 (https=)
GB (1) GB2377221B (https=)
MX (1) MXPA02009069A (https=)
PL (1) PL358230A1 (https=)
WO (1) WO2001070949A1 (https=)

Families Citing this family (79)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6506559B1 (en) 1997-12-23 2003-01-14 Carnegie Institute Of Washington Genetic inhibition by double-stranded RNA
CN101818145A (zh) 1998-03-20 2010-09-01 联邦科学和工业研究组织 控制基因表达
AUPP249298A0 (en) 1998-03-20 1998-04-23 Ag-Gene Australia Limited Synthetic genes and genetic constructs comprising same I
CA2361201A1 (en) 1999-01-28 2000-08-03 Medical College Of Georgia Research Institute, Inc. Composition and method for in vivo and in vitro attenuation of gene expression using double stranded rna
DE19956568A1 (de) 1999-01-30 2000-08-17 Roland Kreutzer Verfahren und Medikament zur Hemmung der Expression eines vorgegebenen Gens
US6423885B1 (en) 1999-08-13 2002-07-23 Commonwealth Scientific And Industrial Research Organization (Csiro) Methods for obtaining modified phenotypes in plant cells
US7531718B2 (en) 1999-08-26 2009-05-12 Monsanto Technology, L.L.C. Nucleic acid sequences and methods of use for the production of plants with modified polyunsaturated fatty acids
ATE383433T1 (de) 1999-08-26 2008-01-15 Calgene Llc Pflanzen mit veränderten mehrfachungesättigten fettsäuren
US7067722B2 (en) 1999-08-26 2006-06-27 Monsanto Technology Llc Nucleic acid sequences and methods of use for the production of plants with modified polyunsaturated fatty acids
DE10100586C1 (de) 2001-01-09 2002-04-11 Ribopharma Ag Verfahren zur Hemmung der Expression eines Ziegens
US7829693B2 (en) 1999-11-24 2010-11-09 Alnylam Pharmaceuticals, Inc. Compositions and methods for inhibiting expression of a target gene
US8202979B2 (en) 2002-02-20 2012-06-19 Sirna Therapeutics, Inc. RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid
WO2003070918A2 (en) 2002-02-20 2003-08-28 Ribozyme Pharmaceuticals, Incorporated Rna interference by modified short interfering nucleic acid
US8273866B2 (en) 2002-02-20 2012-09-25 Merck Sharp & Dohme Corp. RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (SINA)
US7767802B2 (en) 2001-01-09 2010-08-03 Alnylam Pharmaceuticals, Inc. Compositions and methods for inhibiting expression of anti-apoptotic genes
US8546143B2 (en) 2001-01-09 2013-10-01 Alnylam Pharmaceuticals, Inc. Compositions and methods for inhibiting expression of a target gene
US7423142B2 (en) 2001-01-09 2008-09-09 Alnylam Pharmaceuticals, Inc. Compositions and methods for inhibiting expression of anti-apoptotic genes
CA2369944A1 (en) 2001-01-31 2002-07-31 Nucleonics Inc. Use of post-transcriptional gene silencing for identifying nucleic acid sequences that modulate the function of a cell
US9994853B2 (en) 2001-05-18 2018-06-12 Sirna Therapeutics, Inc. Chemically modified multifunctional short interfering nucleic acid molecules that mediate RNA interference
US7517864B2 (en) 2001-05-18 2009-04-14 Sirna Therapeutics, Inc. RNA interference mediated inhibition of vascular endothelial growth factor and vascular endothelial growth factor receptor gene expression using short interfering nucleic acid (siNA)
US20050148530A1 (en) 2002-02-20 2005-07-07 Sirna Therapeutics, Inc. RNA interference mediated inhibition of vascular endothelial growth factor and vascular endothelial growth factor receptor gene expression using short interfering nucleic acid (siNA)
IL159756A0 (en) 2001-07-12 2004-06-20 Univ Massachusetts IN VIVO PRODUCTION OF SMALL INTERFERING RNAs THAT MEDIATE GENE SILENCING
DK2280070T3 (en) 2001-07-23 2015-08-24 Univ Leland Stanford Junior Methods and compositions for use in RNAi-mediated inhibition of gene expression in mammals
US10590418B2 (en) 2001-07-23 2020-03-17 The Board Of Trustees Of The Leland Stanford Junior University Methods and compositions for RNAi mediated inhibition of gene expression in mammals
US20050037989A1 (en) * 2001-08-27 2005-02-17 Lewis David L. Inhibition of gene function by delivery of polynucleotide-based gene expression inhibitors to mammalian cells in vivo
US7745418B2 (en) 2001-10-12 2010-06-29 Alnylam Pharmaceuticals, Inc. Compositions and methods for inhibiting viral replication
DE10163098B4 (de) 2001-10-12 2005-06-02 Alnylam Europe Ag Verfahren zur Hemmung der Replikation von Viren
DE10202419A1 (de) 2002-01-22 2003-08-07 Ribopharma Ag Verfahren zur Hemmung der Expression eines durch eine Chromosomen-Aberration entstandenen Zielgens
US9181551B2 (en) 2002-02-20 2015-11-10 Sirna Therapeutics, Inc. RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)
EP1432724A4 (en) 2002-02-20 2006-02-01 Sirna Therapeutics Inc RNA inhibition mediated inhibition of MAP KINASE GENES
US9657294B2 (en) 2002-02-20 2017-05-23 Sirna Therapeutics, Inc. RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)
US7601888B2 (en) 2002-03-21 2009-10-13 Monsanto Technology L.L.C. Nucleic acid constructs and methods for producing altered seed oil compositions
US7166771B2 (en) 2002-06-21 2007-01-23 Monsanto Technology Llc Coordinated decrease and increase of gene expression of more than one gene using transgenic constructs
US7566813B2 (en) 2002-03-21 2009-07-28 Monsanto Technology, L.L.C. Nucleic acid constructs and methods for producing altered seed oil compositions
US7527966B2 (en) 2002-06-26 2009-05-05 Transgenrx, Inc. Gene regulation in transgenic animals using a transposon-based vector
US20040172667A1 (en) 2002-06-26 2004-09-02 Cooper Richard K. Administration of transposon-based vectors to reproductive organs
US20040241854A1 (en) 2002-08-05 2004-12-02 Davidson Beverly L. siRNA-mediated gene silencing
US20080274989A1 (en) 2002-08-05 2008-11-06 University Of Iowa Research Foundation Rna Interference Suppression of Neurodegenerative Diseases and Methods of Use Thereof
US20050042646A1 (en) 2002-08-05 2005-02-24 Davidson Beverly L. RNA interference suppresion of neurodegenerative diseases and methods of use thereof
WO2004015062A2 (en) 2002-08-12 2004-02-19 New England Biolabs, Inc. Methods and compositions relating to gene silencing
US7923547B2 (en) 2002-09-05 2011-04-12 Sirna Therapeutics, Inc. RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)
CA2501752A1 (en) 2002-10-10 2004-04-22 Wyeth Compositions, organisms and methodologies employing a novel human kinase
EP1554385A2 (en) 2002-10-24 2005-07-20 Wyeth Calcineurin-like human phoshphoesterase
CA2505416A1 (en) 2002-11-21 2004-06-10 Wyeth Methods for diagnosing rcc and other solid tumors
AU2003290664A1 (en) 2002-11-27 2004-06-23 Wei Liu Compositions, organisms and methodologies employing a novel human kinase
WO2005009346A2 (en) * 2003-06-24 2005-02-03 Mirus Corporation Inhibition of gene function by delivery of polynucleotide-based gene expression inhibitors to mammalian cells in vivo
CN1871341A (zh) 2003-08-20 2006-11-29 悉尼北方和中部海岸区医疗服务系统 提高胚胎生存力的方法
JP4353945B2 (ja) * 2003-09-22 2009-10-28 独立行政法人理化学研究所 効率的なｄｎａ逆位反復構造の調製方法
DE10351149A1 (de) * 2003-11-03 2005-06-30 Beiersdorf Ag Oligoribonukleotide zur Behandlung von unerwünschter Pigmentierung der Haut und der Haare durch RNA-Interferenz
US8071364B2 (en) 2003-12-24 2011-12-06 Transgenrx, Inc. Gene therapy using transposon-based vectors
ATE452188T1 (de) 2004-02-10 2010-01-15 Sirna Therapeutics Inc Rna-interferenz-vermittelte hemmung der genexpression unter verwendung multifunktioneller sina (short interfering nucleic acid)
EP1747022A4 (en) 2004-04-23 2010-03-31 Univ Columbia INHIBITION OF HAIRLESS PROTEIN MRNA
US10508277B2 (en) 2004-05-24 2019-12-17 Sirna Therapeutics, Inc. Chemically modified multifunctional short interfering nucleic acid molecules that mediate RNA interference
EP1789070B1 (en) 2004-08-03 2012-10-24 Biogen Idec MA Inc. Taj in neuronal function
EP1799029B1 (en) 2004-10-13 2012-05-16 University Of Georgia Research Foundation, Inc. Nematode resistant transgenic plants
EP2500429A3 (en) 2005-05-31 2015-10-28 Devgen N.V. RNAi for the control of insects and arachnids
WO2007039454A1 (en) 2005-09-20 2007-04-12 Basf Plant Science Gmbh Methods for controlling gene expression using ta-siran
EP1934348B1 (en) 2005-10-11 2018-05-02 Ben-Gurion University Of The Negev Research And Development Authority Compositions for silencing the expression of vdac1 and uses thereof
EP2468901B1 (en) 2005-11-29 2017-04-05 Cambridge Enterprise Limited Markers for breast cancer
PT1981902E (pt) 2006-01-27 2015-11-02 Biogen Ma Inc Antagonistas dos recetores nogo
CN101421406B (zh) 2006-02-13 2016-08-31 孟山都技术有限公司 用于产生改变的种子油组成的核酸构建体和方法
FR2898908A1 (fr) 2006-03-24 2007-09-28 Agronomique Inst Nat Rech Procede de preparation de cellules aviaires differenciees et genes impliques dans le maintien de la pluripotence
KR101670085B1 (ko) 2006-07-21 2016-10-28 사일런스 테라퓨틱스 게엠베하 단백질 키나아제 3의 발현을 억제하기 위한 수단
BRPI0807350A2 (pt) 2007-02-05 2014-05-06 Univ Singapore Receptor de quitocina putativa e métodos para uso do mesmo
EP2129680B1 (en) 2007-03-21 2015-05-06 Brookhaven Science Associates, LLC Combined hairpin-antisense compositions and methods for modulating expression
ES2525045T3 (es) 2008-04-24 2014-12-16 Newsouth Innovations Pty Limited Agrupación de genes de saxitoxina de cianobacterias y detección de organismos cianotóxicos
US8093043B2 (en) 2008-06-04 2012-01-10 New York University β-TrCP1, β-TrCP2 and RSK1 or RSK2 inhibitors and methods for sensitizing target cells to apoptosis
WO2010036978A2 (en) 2008-09-25 2010-04-01 Transgenrx, Inc. Novel vectors for production of growth hormone
WO2010036976A2 (en) 2008-09-25 2010-04-01 Transgenrx, Inc. Novel vectors for production of antibodies
CN107699545A (zh) 2008-09-29 2018-02-16 孟山都技术公司 大豆转基因时间mon87705及其检测方法
MY159849A (en) 2008-12-22 2017-02-15 Lek Pharmaceuticals Mammalian expression vector
EP2241627A1 (en) * 2009-04-17 2010-10-20 LEK Pharmaceuticals d.d. Mammalian expression vector
US9150881B2 (en) 2009-04-09 2015-10-06 Proteovec Holding, L.L.C. Production of proteins using transposon-based vectors
ES2644055T3 (es) 2009-06-05 2017-11-27 Centenary Institute Of Cancer Medicine And Cell Biology Moléculas terapéuticas y de diagnóstico
EP3000885B1 (en) 2009-12-18 2018-07-25 Arrowhead Pharmaceuticals, Inc. Organic compositions to treat hsf1-related diseases
US20120296403A1 (en) 2010-02-10 2012-11-22 Novartis Ag Methods and compounds for muscle growth
WO2012058210A1 (en) 2010-10-29 2012-05-03 Merck Sharp & Dohme Corp. RNA INTERFERENCE MEDIATED INHIBITION OF GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACIDS (siNA)
EP2802658A2 (en) 2012-01-09 2014-11-19 Novartis AG Rnai agents to treat beta-catenin related diseases
KR102699584B1 (ko) 2015-02-02 2024-08-28 메이라지티엑스 유케이 Ii 리미티드 대안적 스플라이싱의 압타머 매개 조절에 의한 유전자 발현 제어

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5208149A (en) * 1983-10-20 1993-05-04 The Research Foundation Of State University Of New York Nucleic acid constructs containing stable stem and loop structures
US5190931A (en) * 1983-10-20 1993-03-02 The Research Foundation Of State University Of New York Regulation of gene expression by employing translational inhibition of MRNA utilizing interfering complementary MRNA
US5272065A (en) * 1983-10-20 1993-12-21 Research Foundation Of State University Of New York Regulation of gene expression by employing translational inhibition of MRNA utilizing interfering complementary MRNA
US4766072A (en) * 1985-07-17 1988-08-23 Promega Corporation Vectors for in vitro production of RNA copies of either strand of a cloned DNA sequence
US5034323A (en) * 1989-03-30 1991-07-23 Dna Plant Technology Corporation Genetic engineering of novel plant phenotypes
US5231020A (en) * 1989-03-30 1993-07-27 Dna Plant Technology Corporation Genetic engineering of novel plant phenotypes
US5714323A (en) * 1991-08-30 1998-02-03 The University Of Medecine And Dentistry Of New Jersey Over expression of single-stranded molecules
CA2130454C (en) * 1992-02-19 2008-04-08 William G. Dougherty Production of viral resistant plants via introduction of untranslatable plus sense viral rna
DE4208107A1 (de) * 1992-03-13 1993-09-16 Bayer Ag Pseudorabies-virus (prv)-polynukleotide und ihre verwendung zur herstellung von virusresistenten eukaryotischen zellen
US5624803A (en) * 1993-10-14 1997-04-29 The Regents Of The University Of California In vivo oligonucleotide generator, and methods of testing the binding affinity of triplex forming oligonucleotides derived therefrom
US5578716A (en) * 1993-12-01 1996-11-26 Mcgill University DNA methyltransferase antisense oligonucleotides
US5686649A (en) * 1994-03-22 1997-11-11 The Rockefeller University Suppression of plant gene expression using processing-defective RNA constructs
US6054299A (en) * 1994-04-29 2000-04-25 Conrad; Charles A. Stem-loop cloning vector and method
NZ333802A (en) * 1996-08-02 2001-09-28 Genesense Technologies Inc Antitumor antisense sequences directed against R1 and R2 components of ribonucleotide reductase
US5814500A (en) * 1996-10-31 1998-09-29 The Johns Hopkins University School Of Medicine Delivery construct for antisense nucleic acids and methods of use
EP1021525A1 (en) * 1997-12-20 2000-07-26 Genencor International, Inc. Fluidized bed matrix granule
US6506559B1 (en) * 1997-12-23 2003-01-14 Carnegie Institute Of Washington Genetic inhibition by double-stranded RNA
CN101818145A (zh) * 1998-03-20 2010-09-01 联邦科学和工业研究组织 控制基因表达
AUPP249298A0 (en) * 1998-03-20 1998-04-23 Ag-Gene Australia Limited Synthetic genes and genetic constructs comprising same I
CN1202246C (zh) * 1998-04-08 2005-05-18 联邦科学和工业研究组织 获得修饰表型的方法和措施
CA2361201A1 (en) * 1999-01-28 2000-08-03 Medical College Of Georgia Research Institute, Inc. Composition and method for in vivo and in vitro attenuation of gene expression using double stranded rna
US6423885B1 (en) * 1999-08-13 2002-07-23 Commonwealth Scientific And Industrial Research Organization (Csiro) Methods for obtaining modified phenotypes in plant cells
GB9927444D0 (en) * 1999-11-19 2000-01-19 Cancer Res Campaign Tech Inhibiting gene expression
ES2336887T5 (es) * 2000-03-30 2019-03-06 Whitehead Inst Biomedical Res Mediadores de interferencia por ARN específicos de secuencias de ARN
JP2004512020A (ja) * 2000-06-23 2004-04-22 イー・アイ・デュポン・ドウ・ヌムール・アンド・カンパニー 組換え構築物ならびにこれを遺伝子発現を減少させる際に用いる方法
US7109393B2 (en) * 2000-08-15 2006-09-19 Mendel Biotechnology, Inc. Methods of gene silencing using inverted repeat sequences

Similar Documents

Publication Publication Date Title
JP2003527856A5 (https=)
US11332726B2 (en) Permanent gene correction by means of nucleotide-modified messenger RNA
JP4718379B2 (ja) 修飾された低分子干渉ｒｎａ分子および使用方法
US6013487A (en) Chimeric RNA molecules generated by trans-splicing
US7985581B2 (en) Multiple RNA polymerase III promoter expression constructs
JP2012506254A5 (https=)
JP2003517580A5 (https=)
AU2017235333A1 (en) CRISPR/CAS-related methods and compositions for treating beta hemoglobinopathies
EP3368670A1 (en) Crispr/cas-related methods and compositions for treating herpes simplex virus
Le Nouën et al. Attenuation of human respiratory viruses by synonymous genome recoding
JP2004511201A5 (https=)
KR900700603A (ko) 리보자임
CN103333890A (zh) 治疗乙型病毒性肝炎的rna干扰制剂
CN111094549B (zh) 用于将体细胞重编程的rna复制子
JP2010029212A (ja) Ｃ型肝炎ウイルスの働きを阻害するオリゴリボヌクレオチドまたはペプチド核酸
Lazinski et al. Regulation of the hepatitis delta virus ribozymes: to cleave or not to cleave?
JP7755272B2 (ja) 操作されたａｄａｒ動員ｒｎａ及びその使用方法
Casey RNA editing in hepatitis delta virus genotype III requires a branched double-hairpin RNA structure
US20050059617A1 (en) Novel anitsense oligonucleotide derivatives against to hepatitis c virus
KR102213837B1 (ko) 유전자가 조작된 nk 세포 및 이의 이용방법
JP3325579B2 (ja) 新規遺伝子組換え体
CN119082107A (zh) 一种ires样五聚体组合翻译启动子、多基因可翻译环状信使rna、多靶点核酸药物及制备方法和应用
TW202503063A (zh) 用於表現ｉｌ－１ｒａ和ｉｌ－１８ｂｐ的組合物和方法
KR100741374B1 (ko) 동물에서 아데노바이러스의 증식을 억제하는 방법
JP2005040070A5 (https=)